Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms.

Cong, Shanshan; Guo, Qiuyan; Cheng, Yan; He, Yanan; Zhao, Xibo; Kong, Congcong; Ning, Shangwei; Zhang, Guangmei

Cong, Shanshan; Guo, Qiuyan; Cheng, Yan; He, Yanan; Zhao, Xibo; Kong, Congcong; Ning, Shangwei; Zhang, Guangmei.

Afiliación

Cong S; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Guo Q; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Cheng Y; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
He Y; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Zhao X; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Kong C; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.
Ning S; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
Zhang G; Department of Gynecology, The First Affiliated Hospital, Harbin Medical University, Harbin, China.

Front Cell Dev Biol ; 8: 614139, 2020.

Article en En | MEDLINE | ID: mdl-33409283

Palabras clave

CIBERSORT; immune; ovarian cancer; prognosis; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Cell Dev Biol Año: 2020 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google